Nutrition science is almost always a hot, steaming pile of contradictory nonsense. How much worse, then, that our eating habits and dietary guidelines are shaped by the government (and its corporate string-pullers)? Join James for this extra tasty, sugar-free, all organic, non-GMO edition of The Corbett Report.
SHOW NOTES at:
A report issued last month by some of the country’s leading election security experts found that voting machines used in dozens of states remain vulnerable to hacks and manipulations. The report warned that that without continued efforts to increase funding, upgrade technology, and adopt of voter-marked paper ballot systems, “we fear that the 2020 presidential elections will realize the worst fears only hinted at during the 2016 elections: insecure, attacked, and ultimately distrusted.”1
The report urges election officials to use machines relying on voter-marked paper ballots and pair those with “statistically rigorous post-election audits” to verify the outcome of elections reflects the will of voters. The authors also warn that supply chain issues “continue to pose significant security risks,”1 including cases where machines include hardware components of foreign origin, or where election administrators deploy foreign-based software, cloud, or other remote services. The report lands as officials in several states are working to upgrade election equipment, and as lawmakers in Washington, D.C. debate federal election security legislation and funding.
Ultimately, the report notes flaws that have been acknowledged for years.
“As disturbing as this outcome is, we note that it is at this point an unsurprising result,” the authors conclude. “However, it is notable—and especially disappointing—that many of the specific vulnerabilities reported over a decade earlier…are still present in these systems today.”1
POTSDAM, Germany (Reuters) – Germany’s attempt to create a multicultural society has “utterly failed,” Chancellor Angela Merkel said on Saturday, adding fuel to a debate over immigration and Islam polarizing her conservative camp.
Speaking to a meeting of young members of her Christian Democrats (CDU), Merkel said allowing people of different cultural backgrounds to live side by side without integrating had not worked in a country that is home to some four million Muslims.
“This (multicultural) approach has failed, utterly failed,” Merkel told the meeting in Potsdam, south of Berlin.
Merkel faces pressure from within her CDU to take a tougher line on immigrants who don’t show a willingness to adapt to German society and her comments appeared intended to pacify her critics…
The most lucrative harvest in this economic network flow is of course the humans who will be forced to pay for toxic and expensive genetically vandalized pot. Meanwhile the prison industrial combine will continue reaping its own human harvest unimpeded.
Canada is to become the second country after Uruguay to legalize the recreational use of cannabis. Adults will be able to purchase cannabis from “federally licensed producers”. At present, Canada has according to the BBC “one of the highest rates of cannabis use” Worldwide. “Canadians spent an estimated C$5.7bn ($4.6bn; £3.5bn) in 2017 alone on combined medical and recreational use – about $1,200 per user. The bulk of that spending was on black market marijuana.” (BBC, October 14, 2018).
Legalization kills the black market. Who is going to benefit? Ellen Brown analyses the corporate interests behind the legalization of Marijuana. It’s a multibillion corporate bonanza. In the US, the push has come from Big Pharma and Big Ag with Bayer-Monsanto in the lead.
California’s “Adult Use of Marijuana Act” (AUMA) is a voter initiative characterized as legalizing marijuana use. But critics warn that it will actually make access more difficult and expensive, squeeze home growers and small farmers out of the market, heighten criminal sanctions for violations, and open the door to patented, genetically modified (GMO) versions that must be purchased year after year.
As detailed in Part I of this article, the health benefits of cannabis are now well established. It is a cheap, natural alternative effective for a broad range of conditions, and the non-psychoactive form known as hemp has thousands of industrial uses. At one time, cannabis was one of the world’s most important crops. There have been no recorded deaths from cannabis overdose in the US, compared to about 30,000 deaths annually from alcohol abuse (not counting auto accidents), and 100,000 deaths annually from prescription drugs taken as directed. Yet cannabis remains a Schedule I controlled substance (“a deadly dangerous drug with no medical use and high potential for abuse”), illegal to be sold or grown in the US.
Powerful corporate interests no doubt had a hand in keeping cannabis off the market. The question now is why they have suddenly gotten on the bandwagon for its legalization. According to an April 2014 article in The Washington Times, the big money behind the recent push for legalization has come, not from a grassroots movement, but from a few very wealthy individuals with links to Big Ag and Big Pharma.
Leading the charge is George Soros, a major shareholder in Monsanto, the world’s largest seed company and producer of genetically modified seeds. Monsanto is the biotech giant that brought you Agent Orange, DDT, PCBs, dioxin-based pesticides, aspartame, rBGH (genetically engineered bovine growth hormone), RoundUp (glyphosate) herbicides, and RoundUp Ready crops (seeds genetically engineered to withstand glyphosate).
Monsanto now appears to be developing genetically modified (GMO) forms of cannabis, with the intent of cornering the market with patented GMO seeds just as it did with GMO corn and GMO soybeans. For that, the plant would need to be legalized but still tightly enough controlled that it could be captured by big corporate interests. Competition could be suppressed by limiting access to homegrown marijuana; bringing production, sale and use within monitored and regulated industry guidelines; and legislating a definition of industrial hemp as a plant having such low psychoactivity that only GMO versions qualify. Those are the sorts of conditions that critics have found buried in the fine print of the latest initiatives for cannabis legalization.
Patients who use the cannabis plant in large quantities to heal serious diseases (e.g. by juicing it) find that the natural plant grown organically in sunlight is far more effective than hothouse plants or pharmaceutical cannabis derivatives. Letitia Pepper is a California attorney and activist who uses medical marijuana to control multiple sclerosis. As she puts it, if you don’t have an irrevocable right to grow a natural, therapeutic herb in your backyard that a corporation able to afford high license fees can grow and sell to you at premium prices, isn’t that still a war on people who use marijuana?
Follow the Money to Uruguay
Monsanto has denied that it is working on GMO strains. But William Engdahl, author ofSeeds of Destruction: The Hidden Agenda of Genetic Manipulation, presents compelling circumstantial evidence to the contrary. In a March 2014 article titled “The Connection Between the Legalization of Marijuana in Uruguay, Monsanto and George Soros”, Engdahl observes that in 2014, Uruguay became the first country to legalize the cultivation, sale and consumption of marijuana. Soros is a major player in Uruguay and was instrumental in getting the law passed. He sits on the board of the New York-based Drug Policy Alliance (DPA), the world’s most influential organization for cannabis legalization. The DPA is active not only in the US but in Uruguay and other Latin American countries. Engdahl writes:
Studies show that Monsanto without much fanfare conducts research projects on the active ingredient in marijuana, namely THC (tetrahydrocannabinol), in order to genetically manipulate the plant. David Watson of the Dutch company Hortapharm has since 1990 created the world’s largest collection of Cannabis seed varieties. In 1998, the British firm GW Pharmaceuticals signed an agreement with Hortapharm that gives GW Pharma the rights to use the Hortapharm cannabis for their research.
In 2003 the German Bayer AG then signed an agreement with GW Pharmaceuticals for joint research on a cannabis-based extract. In 2007, Bayer AG agreed to an exchange of technology with . . . Monsanto . . . . Thus Monsanto has discreet access to the work of the cannabis plant and its genetic modification. In 2009 GW Pharmaceuticals announced that it had succeeded in genetically altering a cannabis plant and patented a new breed of cannabis….